Test Price
2,800 AED✅ Home Collection Available
DMD Gene (Becker‑Type Muscular Dystrophy) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين DMD (الحثل العضلي من نوع بيكر) باستخدام التسلسل الجيني الشامل (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- ✓ ضمان الدقة: حساسية تشخيصية 99.9% عبر معالجة معتمدة بموجب ISO (الشهادة INT/EGQ/2509DA/3139).
- ✓ الخدمة اللوجستية الممتازة: خدمة السحب المنزلي بمعايير المستشفيات عبر سلسلة تبريد معتمدة ISO، وفريق تمريض متنقل VIP.
- ✓ التوجيه السريري: استشارة هاتفية بعد الفحص لتفسير النتائج من قبل أطباء متخصصين.
- ✓ التأمين: تحقق مباشر من تغطية التأمين عبر واتساب +971 54 548 8731.
Overview
The DMD Gene NGS test detects pathogenic variants in the dystrophin gene linked to Becker muscular dystrophy, enabling early diagnosis, carrier status assessment, and family planning.
يكشف تحليل جين DMD بتقنية التسلسل الجيني الشامل (NGS) عن الطفرات المسببة للحثل العضلي من نوع بيكر، مما يتيح التشخيص المبكر وتقييم الحالة الحاملة للجين وتخطيط الأسرة.
| Feature | DMD NGS Test (Our Test) | Closest Alternative |
|---|---|---|
| Precision | Single‑nucleotide resolution, full gene coverage (deletions, duplications, point mutations) | Limited to exon‑level copy number variations (MLPA) |
| Method | Next‑Generation Sequencing (NGS), validated by ISO 9001:2015 | Multiplex Ligation‑dependent Probe Amplification (MLPA) ± Sanger sequencing |
| Turnaround Time | 3–4 Weeks (cold‑chain, from sample arrival) | 4–6 Weeks (often fragmented serial testing) |
Clinical Indications & Ordering Specialists
This genetic test is prescribed exclusively by DHA‑licensed physicians. The three primary specialist categories and their clinical intent are:
- Neurologist – confirms diagnosis of Becker‑type dystrophinopathy in patients with progressive proximal weakness and elevated CK; differentiates from limb‑girdle muscular dystrophies.
- Clinical Geneticist (Medical Genetics Consultant) – evaluates positive family history, identifies carrier status in asymptomatic females, and provides risk assessment.
- Genetic Counsellor – conducts pre‑test counselling, draws a detailed pedigree chart, and explains inheritance patterns, test limitations, and reproductive options.
Physician Insight & Safety Protocol
“Genetic results must be correlated with clinical phenotype and comprehensive family history. A negative NGS result does not exclude other dystrophin mutations or non‑dystrophin myopathies. Always interpret findings in the context of a complete neuromuscular evaluation.”
— Dr. Prabhakar Reddy, DHA License 61713011, Consultant Neurologist
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Stopping corticosteroids or other treatments abruptly may accelerate muscle degeneration and trigger life‑threatening adrenal crisis.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Do not collect sample if the patient has received a blood transfusion in the last 120 days; donor DNA may confound results.
- Exclusion: Test not indicated without prior genetic counselling – a pedigree chart and informed consent are mandatory under UAE CDS Law 2026 for minors.
- Red Flag: Sudden onset of double vision, drooping eyelids (ptosis), or difficulty swallowing – seek emergency neurological evaluation.
- Red Flag: Rapidly worsening breathing difficulty or orthopnea – call 998 immediately for acute respiratory support.
Patient FAQ & Clinical Guidance
Q: What exactly does the DMD gene NGS test detect?
A: This test sequences the entire dystrophin gene to identify deletions, duplications, and point mutations responsible for Becker muscular dystrophy. (Test includes analysis of all 79 exons and deep intronic regions, detecting variants down to single‑nucleotide resolution with 99.9% analytical sensitivity.)
يكشف التحليل عن جميع أنواع التغيرات في جين الديستروفين (الحذف، التضاعف، الطفرات النقطية) المرتبطة بحثل العضلات بيكر.
Q: How is the sample collected, and is home service available?
A: A DHA‑certified phlebotomist performs a painless venipuncture at your home (8 AM–11 PM) using an ISO‑certified cold‑chain kit. (Dried blood spot cards can be used for infants and patients with difficult venous access; extracted DNA from existing samples is also accepted.)
تتوفر خدمة سحب الدم المنزلي من الساعة 8 صباحاً حتى 11 مساءً، مع خيار استخدام بقعة الدم الجافة على بطاقة FTA لتجنب الألم للأطفال.
Q: Will the result change my treatment or prognosis?
A: A positive result confirms the molecular diagnosis and allows targeted multidisciplinary care planning, carrier testing for relatives, and access to disease‑modifying therapies when available. (Your neurologist will explain how specific mutations influence clinical severity and expected trajectory, but never alter medication without professional supervision.)
النتيجة الإيجابية تُثبت التشخيص الجزيئي وتُساعد على وضع خطة رعاية متعددة التخصصات، إضافةً إلى فحص أفراد العائلة وتحديد خيارات العلاج المناسبة.
UAE Legal Compliance: This service strictly adheres to Federal Decree‑Law No. 41 of 2024 (Art. 87) on Medical Liability, UAE Child Protection (CDS) Law 2026 for minor consent, and UAE PDPL for data privacy. All personnel are DHA‑licensed. Laboratory certificate: 9834453. ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
For emergency medical assistance, dial 998. For clarification, contact WhatsApp: +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians